Abstract
Developing disease-modifying treatments for Alzheimer dementia requires innovative approaches to identify novel biological targets during the course of the disease. Treatment development for the neuropsychiatric symptoms of Alzheimer may benefit from a mechanistic approach to treatment. There has been progress in identifying mild forms of behavioral impairment along the Alzheimer spectrum that may lead to additional insights into progression to dementia as well as the fundamental mechanisms of the symptoms. Developing therapies for complex neurobehavioral syndromes may require the translation of mechanistic insights into therapy, which may both improve the symptoms and delay progression to dementia in certain patients.
Original language | English (US) |
---|---|
Pages (from-to) | 383-397 |
Number of pages | 15 |
Journal | Psychiatric Clinics of North America |
Volume | 43 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2020 |
Keywords
- Agitation
- Alzheimer
- Apathy
- Behavior
- Dementia
- Depression
- Neuropsychiatric
ASJC Scopus subject areas
- Psychiatry and Mental health